• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例术前前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)显示阴性但已发生后腹膜转移的前列腺腺癌患者的病例报告。

A Case Report of a Patient With Prostate Adenocarcinoma Metastatic to the Posterior Peritoneum Despite the Negative Preoperative Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Scan.

作者信息

Shoeleh Celeste, Graff John, Patel Trushar

机构信息

Department of Urology, University of South Florida, Tampa, USA.

Department of Pediatric Oncology, USF (University of South Florida) Health, Tampa, USA.

出版信息

Cureus. 2023 Jun 4;15(6):e39948. doi: 10.7759/cureus.39948. eCollection 2023 Jun.

DOI:10.7759/cureus.39948
PMID:37416002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10319601/
Abstract

Despite the role of prostate-specific antigen (PSA) screening and the multitude of therapies available, prostate cancer (PCa) remains a leading cause of cancer-related morbidity and mortality. For many patients diagnosed with PCa, clinical and radiographic staging are critical components for management decisions. PCa staging with the use of imaging modalities such as MRI and bone scintigraphy is recommended in patients with newly diagnosed intermediate or high-risk PCa and in patients with biochemical recurrence; it is also recommended for monitoring the patient's response to treatment for diagnosed PCa. Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT), recently approved in 2021, is an imaging modality that has been shown to have a greater sensitivity, specificity, and negative likelihood ratio than conventional imaging modalities such as CT, bone scintigraphy, and MRI in prostate cancer staging. Despite the improvement in staging that PSMA-PET/CT can provide, our current report details a false-negative result in detecting a rare PCa metastasis to the peritoneum, which was found at the time of an attempted radical prostatectomy. Although the patient had a negative preoperative PSMA-PET/CT and was presumed to be non-metastatic, the prostatectomy was aborted because the patient was unexpectedly found to have peritoneal metastasis.

摘要

尽管前列腺特异性抗原(PSA)筛查发挥了作用,且有多种治疗方法可供选择,但前列腺癌(PCa)仍然是癌症相关发病和死亡的主要原因。对于许多被诊断为PCa的患者而言,临床和影像学分期是管理决策的关键组成部分。对于新诊断为中危或高危PCa的患者以及生化复发的患者,建议使用MRI和骨闪烁显像等成像方式进行PCa分期;对于监测已诊断PCa患者对治疗的反应也建议进行分期。前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)于2021年获得批准,是一种成像方式,在前列腺癌分期方面已显示出比CT、骨闪烁显像和MRI等传统成像方式具有更高的敏感性、特异性和阴性似然比。尽管PSMA-PET/CT能够在分期方面带来改善,但我们当前的报告详细阐述了在检测一例罕见的前列腺癌腹膜转移时出现的假阴性结果,该转移是在尝试进行根治性前列腺切除术时发现的。尽管该患者术前PSMA-PET/CT结果为阴性且被假定无转移,但由于意外发现患者存在腹膜转移,前列腺切除术被中止。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/593b/10319601/a03455b9bb01/cureus-0015-00000039948-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/593b/10319601/0ae830a34f36/cureus-0015-00000039948-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/593b/10319601/ecbf60bd8502/cureus-0015-00000039948-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/593b/10319601/a03455b9bb01/cureus-0015-00000039948-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/593b/10319601/0ae830a34f36/cureus-0015-00000039948-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/593b/10319601/ecbf60bd8502/cureus-0015-00000039948-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/593b/10319601/a03455b9bb01/cureus-0015-00000039948-i03.jpg

相似文献

1
A Case Report of a Patient With Prostate Adenocarcinoma Metastatic to the Posterior Peritoneum Despite the Negative Preoperative Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Scan.一例术前前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)显示阴性但已发生后腹膜转移的前列腺腺癌患者的病例报告。
Cureus. 2023 Jun 4;15(6):e39948. doi: 10.7759/cureus.39948. eCollection 2023 Jun.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
A Prospective Comparison of F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE).F-前列腺特异性膜抗原-1007 正电子发射断层扫描计算机断层扫描、全身 1.5T 磁共振成像弥散加权成像与传统成像单光子发射计算机断层扫描/计算机断层扫描在前列腺癌原发远处转移分期(PROSTAGE)中的前瞻性比较
Eur Urol Oncol. 2021 Aug;4(4):635-644. doi: 10.1016/j.euo.2020.06.012. Epub 2020 Jul 13.
4
How accurate is Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)在中高危前列腺癌根治性前列腺切除术前对原发性淋巴结分期的准确性如何?一项基于患者和淋巴结的分析研究。
Urol Oncol. 2022 Jan;40(1):6.e1-6.e9. doi: 10.1016/j.urolonc.2021.07.006. Epub 2021 Aug 13.
5
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描与常规成像在初治中高危前列腺癌分期中的比较:一项回顾性单中心研究。
Eur Urol Oncol. 2022 Oct;5(5):544-552. doi: 10.1016/j.euo.2020.08.012. Epub 2020 Sep 18.
6
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.前列腺特异性膜抗原正电子发射断层扫描在新发和生化复发前列腺癌中的应用对转移灶位置的影响及对患者管理的影响:一项关键性综述。
Eur Urol Oncol. 2023 Apr;6(2):128-136. doi: 10.1016/j.euo.2023.01.014. Epub 2023 Feb 16.
7
The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.在新诊断前列腺癌患者中,使用前列腺特异性膜抗原正电子发射断层扫描评估不同前列腺特异性抗原范围内发生转移的概率。
Eur Urol Open Sci. 2023 Dec 22;59:55-62. doi: 10.1016/j.euros.2023.12.001. eCollection 2024 Jan.
8
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
9
Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit.在前列腺癌单 位管理的适合接受根治性前列腺切除术的中高危前列腺癌患者中,使用 68Ga-PSMA PET 进行淋巴结分期。
Chin Clin Oncol. 2023 Jun;12(3):22. doi: 10.21037/cco-23-10.
10
Gallium-68-prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.镓-68-前列腺特异性膜抗原(Ga-PSMA)正电子发射断层扫描(PET)/计算机断层扫描(CT)可预测中高危前列腺癌根治性前列腺切除术和淋巴结清扫术后的完全生化缓解。
BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7.

引用本文的文献

1
A Unique Case of Prostate Carcinoma Presenting as Retroperitoneal Lymphadenopathy With Normal Levels of Prostate-Specific Antigen and a Prostate of Normal Size: A Case Report.一例独特的前列腺癌病例:表现为腹膜后淋巴结病,前列腺特异性抗原水平正常且前列腺大小正常——病例报告
Cureus. 2024 Jan 25;16(1):e52962. doi: 10.7759/cureus.52962. eCollection 2024 Jan.

本文引用的文献

1
A young patient with prostatic carcinoma with testicular metastasis.一名患有前列腺癌并伴有睾丸转移的年轻患者。
Int J Surg Case Rep. 2022 Oct;99:107653. doi: 10.1016/j.ijscr.2022.107653. Epub 2022 Sep 13.
2
Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: First-line imaging is afoot.前列腺特异性膜抗原正电子发射断层扫描在原发性前列腺癌诊断中的应用:一线影像学方法正在发展中。
Cancer Lett. 2022 Nov 1;548:215883. doi: 10.1016/j.canlet.2022.215883. Epub 2022 Aug 24.
3
Unusual Metastatic Prostate Cancer in Subcarinal Lymph Node and Peritoneal Nodule Found on 18 F-PSMA PET/CT With Rising PSA of 0.4 ng/mL.
在18F-PSMA PET/CT上发现隆突下淋巴结和腹膜结节有罕见的转移性前列腺癌,同时前列腺特异性抗原(PSA)升高0.4 ng/mL。
Clin Nucl Med. 2022 Nov 1;47(11):989-990. doi: 10.1097/RLU.0000000000004294. Epub 2022 May 27.
4
Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT.18F-PSMA-1007 PET/CT 检测前列腺癌弥漫性腹膜和网膜转移。
Clin Nucl Med. 2022 Jan 1;47(1):e74-e76. doi: 10.1097/RLU.0000000000003802.
5
Rapidly Evolving Diffuse Omental Carcinomatosis of Prostate Cancer in 68Ga-PSMA PET/CT.68Ga-PSMA PET/CT 中前列腺癌快速进展性弥漫性大网膜转移
Clin Nucl Med. 2021 Apr 1;46(4):e216-e217. doi: 10.1097/RLU.0000000000003414.
6
Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer.前列腺特异性膜抗原 PET/计算机断层扫描在前列腺癌分期中的应用。
Curr Opin Urol. 2020 Sep;30(5):628-634. doi: 10.1097/MOU.0000000000000799.
7
Epidemiology, Staging and Management of Prostate Cancer.前列腺癌的流行病学、分期与管理
Med Sci (Basel). 2020 Jul 20;8(3):28. doi: 10.3390/medsci8030028.
8
FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer.FDG-PET 与 PSMA-PET:一位前列腺癌患者。
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620941313. doi: 10.1177/2324709620941313.
9
Imaging for Metastasis in Prostate Cancer: A Review of the Literature.前列腺癌转移的影像学检查:文献综述
Front Oncol. 2020 Jan 31;10:55. doi: 10.3389/fonc.2020.00055. eCollection 2020.
10
Clinical perspectives of PSMA PET/MRI for prostate cancer.前列腺特异性膜抗原(PSMA)PET/MRI在前列腺癌中的临床应用前景
Clinics (Sao Paulo). 2018 Sep 21;73(suppl 1):e586s. doi: 10.6061/clinics/2018/e586s.